Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
KBC Group NV Has $398.25 Million Stake in Gilead Sciences, Inc. $GILD
Zacks Research Expects Lower Earnings for Gilead Sciences
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $165.00 - Zolmax
Gilead's Lenacapavir Access Push And Pricing Protests Shape HIV Outlook
Gilead Sciences (GILD) to Release Quarterly Earnings on Thursday
Pursuit Wealth Management LLC Acquires Shares of 5,826 Gilead Sciences, Inc. $GILD - Daily Political
Lbp Am Sa Has $27.41 Million Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Cramer's lightning round: Nokia still has room to run
Bingham Private Wealth LLC Invests $1.42 Million in Gilead Sciences, Inc. $GILD
Zacks Research Predicts Weaker Earnings for Gilead Sciences - Daily Political
- Additional Commitment will Expand Access to Lenacapavir to
Is It Too Late To Consider Gilead Sciences (GILD) After Its Strong 1 Year Share Price Run?
Gilead Sciences, Inc. $GILD Shares Purchased by Patton Fund Management Inc. - Markets Daily
1 Profitable Stock for Long-Term Investors and 2 Facing Challenges
Patton Fund Management Inc. Grows Position in Gilead Sciences, Inc. $GILD - Stock Observer
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
Morgan Stanley Boosts Gilead (GILD) Outlook on Updated Biopharma Models
Gilead Sciences (NASDAQ:GILD) Given New $165.00 Price Target at Citigroup
Gilead Sciences, Inc. $GILD Shares Sold by Old North State Wealth Management LLC - Markets Daily
Gilead (GILD), Tempus AI (TEM) Expand Multi-Year Oncology R&D Collaboration
How Investors Are Reacting To Kymera Therapeutics (KYMR) Gilead Option Exercise And US$45M Milestone
Massachusetts Financial Services Co. MA Grows Holdings in Gilead Sciences, Inc. $GILD - Stock Observer
Sumitomo Mitsui Trust Group Inc. Sells 60,405 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Robeco Institutional Asset Management B.V. Sells 108,349 Shares of Gilead Sciences, Inc. $GILD - Daily Political
Does Tempus AI's (TEM) Deeper Gilead Tie Mark a Shift in Its Platform Strategy?
Ritholtz Wealth Management Acquires 7,865 Shares of Gilead Sciences, Inc. $GILD
Gilead Sciences (NASDAQ:GILD) Given New $115.00 Price Target at Cantor Fitzgerald - Stock Observer
Tempus AI (TEM) Stock Surges on Expanded Gilead Partnership for Oncology Data Platform
Tempus AI Gilead Expansion Deepens Role In Oncology Drug Development
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $175.00 - Daily Political
Gilead Sciences (GILD) to Acquire Tubulis for $5B to Strengthen Oncology Pipeline
Jackson Square Capital LLC Takes Position in Gilead Sciences, Inc. $GILD - Markets Daily
Company Website: https://tempus.com CHICAGO -- (Business W
Gilead Sciences, Inc. $GILD Shares Purchased by OFI Invest Asset Management - Markets Daily
How EQT's Buybacks and Tubulis Exit May Reshape EQT (OM:EQT) Investors' Capital Recycling Story
OFI Invest Asset Management Acquires 470,804 Shares of Gilead Sciences, Inc. $GILD
8,451 Shares in Gilead Sciences, Inc. $GILD Bought by Jackson Square Capital LLC
Gilead Sciences, Inc. (NASDAQ:GILD) Receives $157.62 Average Price Target from Analysts - Markets Daily
Gilead Agrees $5 Billion Tubulis Acquisition To Expand Cancer Drug Pipeline
Gilead Sciences, Inc. $GILD Shares Sold by Yousif Capital Management LLC - Markets Daily
Sivik Global Healthcare LLC Buys Shares of 25,000 Gilead Sciences, Inc. $GILD
Gilead Tubulis Deal Expands ADC Oncology Pipeline And Valuation Debate
Is Gilead Sciences (GILD) Among the Best Low Volatility Blue Chip Stocks to Buy Now?
Stock Yards Bank & Trust Co. Has $1.80 Million Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences Details Tubulis, Ouro, Arcellx Deals as Pipeline Catalyst, 2026 Updates Loom
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Multi Year Share Price Run
EQT Life Sciences to exit minority stake in Tubulis via sale to Gilead Sciences for up to USD 5.0 billion
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion - Update | Morningstar
Gilead to buy cancer biotech Tubulis in US$5 billion deal - The Business Times
Gilead to acquire Tubulis GmbH for up to $5 billion
Gilead Sciences (NASDAQ:GILD) Price Target Raised to $123.00 at Royal Bank Of Canada - Stock Observer
Robinhood Asset Management LLC Invests $593,000 in Gilead Sciences, Inc. $GILD - Daily Political
Trueblood Wealth Management LLC Takes Position in Gilead Sciences, Inc. $GILD - Markets Daily
Assessing Gilead Sciences (GILD) Valuation After Its Strong Multi Year Share Price Run
Kelleher Financial Advisors Increases Holdings in Gilead Sciences, Inc. $GILD
Perpetual Ltd Raises Position in Gilead Sciences, Inc. $GILD
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Moderate Buy" by Analysts
Best Pharmaceutical Stocks To Follow Today - April 3rd - Markets Daily
Gilead Sciences Advances Growth Strategy with Focus on HIV
Gilead Sciences, Inc. $GILD Position Reduced by Aberdeen Group plc
Bristol Myers Squibb, Gilead Sciences to review media accounts
HF Advisory Group LLC Buys 13,212 Shares of Gilead Sciences, Inc. $GILD
Banque Pictet & Cie SA Purchases 142,543 Shares of Gilead Sciences, Inc. $GILD
A Look At Gilead Sciences (GILD) Valuation After Recent Mixed Share Price Performance
Gilead Extends Deadline on Tender Offer to Acquire Arcellx | Morningstar
Gilead Sciences's Q1 2026 Earnings: What to Expect
Gilead Sciences, Inc. $GILD Stock Holdings Raised by Nisa Investment Advisors LLC
Gilead Sciences, Inc. $GILD Shares Acquired by Moody Lynn & Lieberson LLC
Meyer Handelman Co. Has $41.33 Million Holdings in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Bought by Mn Services Vermogensbeheer B.V.
Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
6,329 Shares in Gilead Sciences, Inc. $GILD Acquired by WESPAC Advisors LLC
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial
Gilead Sciences, Inc. $GILD Stake Lifted by USA Financial Formulas
5,845 Shares in Gilead Sciences, Inc. $GILD Bought by Parsons Capital Management Inc. RI - Stock Observer
Synergy Asset Management LLC Has $204,000 Holdings in Gilead Sciences, Inc. $GILD
Exchange Traded Concepts LLC Raises Position in Gilead Sciences, Inc. $GILD
Wedge Capital Management L L P NC Sells 10,133 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
CAR T-Cell Therapy Market to Hit USD 13.78 Billion by 2031, Driven by Rising Global Cancer Prevalence - Insights by Product, Target, Indication, Demographic, Region, and Competitive Landscape
Gilead Sciences FY2026 EPS Increased by Erste Group Bank
NatWest Group plc Has $5.40 Million Stock Holdings in Gilead Sciences, Inc. $GILD
FY2026 EPS Forecast for Gilead Sciences Lifted by Analyst - Stock Observer
Gilead Sciences, Inc. $GILD Shares Purchased by Global X Japan Co. Ltd. - Daily Political
Gilead News
Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence
Global Markets Show Resilience Amidst Iran Conflict, But Underlying Risks Persist
BIRD Stock Is Trading Down After Its 582% Surge: What’s happening with Allbirds Inc?
Oil Price Outlook: Saudi Arabia’s Supply Disruptions Fuel Oil Market Volatility, Will WTI Crude Oil Go up?
Iran's Hormuz Toll Strategy: Post-War Economic Leverage and Geopolitical Realignment
Market Performance Overview: S&P 500 Rose 1.18%, Earnings Season Q1 2026, Crypto Positive Sentiment
Apple (AAPL) stock overview: Apple Q2 2026 earnings are coming, what to expect on April 30?
Latest news
Show moreClose Coordination Between Israel and US on Iran Nuclear Talks Highlighted
Federal Reserve Independence Under Historic Test: Navigating Democratic Legitimacy and Political Pressure
Middle East Financial News: Saudi Arabia Steps In with $3 Billion Aid for Pakistan as UAE Demands Debt Repayment
Gold price today, April 16: XAU/USD drifts below $4,800 as the US Dollar strengthens
How is the ZA economy doing right now: What is the current rate of unemployment in South Africa?
